| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-12-23 08:51 Tx date 2020-12-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,550
+9,500 vol $0.90 each |
45,000 | |
| Filed 2020-12-23 08:50 Tx date 2020-12-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$14,355
+16,500 vol $0.87 each |
35,500 | |
| Filed 2020-12-23 08:45 Tx date 2020-12-22 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,740
+9,000 vol $0.86 each |
19,000 | |
| Filed 2020-11-20 15:28 Tx date 2020-11-20 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-6,626.61
-8,181 vol $0.81 each |
10,000 | |
| Filed 2020-11-20 15:26 Tx date 2020-11-18 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-19,920
-24,000 vol $0.83 each |
18,181 | |
| Filed 2020-09-16 13:07 Tx date 2020-09-14 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chiasson, Bernard
5 - Senior Officer of Issuer
Holder: BJC Integrated Scientific Management Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,991
+3,835 vol $0.78 each |
9,485 | |
| Filed 2020-07-02 09:51 Tx date 2020-06-30 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,530
+7,000 vol $0.79 each |
75,000 | |
| Filed 2020-06-17 12:47 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+1,500 vol $0.80 each |
98,886 | |
| Filed 2020-06-17 12:46 Tx date 2020-06-15 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
97,386 | |
| Filed 2020-06-16 16:11 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Loucaides, Katina
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,288 vol |
183,850 | |
| Filed 2020-06-16 16:09 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Chicoine, Daniel
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
139,025 | |
| Filed 2020-06-16 16:06 Tx date 2020-06-16 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
London, John
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-16,608 vol |
328,283 | |
| Filed 2020-06-15 16:54 Tx date 2020-06-12 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,975
+2,500 vol $0.79 each |
94,886 | |
| Filed 2020-06-12 13:23 Tx date 2020-06-11 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
92,386 | |
| Filed 2020-06-11 13:58 Tx date 2020-06-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,340
+3,000 vol $0.78 each |
68,000 | |
| Filed 2020-06-11 13:56 Tx date 2020-06-10 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
89,886 | |
| Filed 2020-06-10 14:07 Tx date 2020-03-13 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,120
+2,000 vol $0.56 each |
36,000 | |
| Filed 2020-06-10 13:25 Tx date 2020-06-09 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
87,386 | |
| Filed 2020-06-10 10:34 Tx date 2020-06-05 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Harris, Robert Paul
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,304
+8,000 vol $0.79 each |
63,000 | |
| Filed 2020-06-09 13:40 Tx date 2020-06-08 |
$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) |
Ledger, Jesse Francis
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+2,500 vol $0.80 each |
84,886 |